In 2026, the condition formerly known as Polycystic Ovary Syndrome was renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). International PMOS Guideline – Monash University The new name is intended to reflect the fact that the condition involves endocrine, metabolic and ovarian disturbances rather than simply an abnormal-looking ovary. The global renaming process involved 3,000+ health professionals, 100+ multidisciplinary experts from 71 countries with lived experience.
And this is where the story gets more interesting.
Because once you stop looking at PMOS as “a problem with the ovaries,” several symptoms that seemed unrelated suddenly start making more sense.
The word “polycystic” created a surprisingly big misunderstanding
One of the biggest misconceptions surrounding PCOS has always been the idea that a woman must have ovarian cysts to have the condition. She doesn't.
The ovarian finding associated with PCOS is usually polycystic ovarian morphology, referring to the number and appearance of follicles or ovarian enlargement—not the presence of pathological cysts that define the disease. In fact, current diagnostic guidance states that ovarian ultrasound is not even necessary for an adult who already has both irregular menstrual cycles and hyperandrogenism.
That changes the way we should think about the condition.
The question is not simply:
“Are there cysts on the ovaries?”
A better question is:
“What is happening across the hormonal, reproductive and metabolic systems?”
That is precisely the broader picture the new term PMOS is trying to capture. The 2026 international consensus described the old name as misleading because it focused attention on ovarian morphology while obscuring endocrine and metabolic features. 2026 PMOS Guideline
PMOS can hide in places you wouldn't expect
Imagine a woman who has been told for years that her only issue is an “irregular period.”
She is not particularly overweight.
Her ultrasound does not look dramatic.
But she has persistent acne, increased facial hair, difficulty predicting her menstrual cycle and symptoms that seem to come and go.
Would you immediately think of PMOS?
This is where clinical assessment matters.
PMOS does not have one universal appearance. Some women present primarily with irregular or absent periods. Others notice hirsutism, acne, scalp hair thinning, weight-management difficulties or fertility problems. Some may also have metabolic abnormalities that are not obvious from appearance alone. WHO notes that symptoms can vary considerably between women and may change over time. WHO – PCOS Fact Sheet
That variability is one reason PMOS can remain undiagnosed.
WHO estimates that around 10–13% of reproductive-aged women worldwide are affected, while up to 70% may not know that they have the condition.
So yes, the woman sitting in front of you may have PMOS without matching the stereotypical picture people have in their heads.
A normal cycle does not always tell the whole story
Here is another detail that often gets overlooked.
A menstrual cycle that arrives regularly does not automatically prove that ovulation is happening normally.
The international guideline notes that ovulatory dysfunction can still occur in women with regular cycles. When it is clinically necessary to confirm ovulation, assessment such as serum progesterone may be used.
That is important because PMOS is not diagnosed by looking at one symptom in isolation.
A period tracker can tell you when bleeding happened. It cannot tell you the whole endocrine story.
The PMOS diagnostic puzzle
There is no single blood test, ultrasound scan or symptom that can diagnose every adult case.
The established diagnostic framework considers three major features:
Ovulatory dysfunction
Clinical or biochemical hyperandrogenism
Polycystic ovarian morphology
In adults, two of these features can establish the diagnosis after other possible causes have been excluded. Anti-Müllerian hormone (AMH) can be used as an alternative to ultrasound for defining polycystic ovarian morphology in appropriate adults, but AMH should not be used as a stand-alone diagnostic test. When irregular cycles and hyperandrogenism are already present, neither ultrasound nor AMH is required for diagnosis.
That means the old mental shortcut—
“No cysts, so no PCOS.”
—is simply too simplistic.
Clinical snapshot: When the scan isn't the whole story
An illustrative clinical scenario
A 26-year-old woman presents with irregular cycles, increased facial hair and persistent adult acne. She is concerned because she has been trying to conceive.
Her ultrasound report does not show what she expected after hearing the word “polycystic.”
She assumes that means she cannot have the syndrome.
But her clinical picture tells a different story.
Her menstrual pattern needs assessment. Her signs of androgen excess need evaluation. Other possible causes need to be excluded. Her reproductive goals also matter.
This is the kind of situation in which looking only at an ultrasound can make a complex endocrine disorder appear deceptively simple.
The guideline specifically confirms that in adults with irregular cycles and hyperandrogenism, an ovarian ultrasound is not required to make the diagnosis.
Then there is the metabolic side
This is where the “M” in PMOS becomes especially interesting.
PMOS is not only about reproductive hormones. Metabolic health matters too.
Insulin resistance is recognized as an important part of the underlying biology of PCOS/PMOS. However, there is an important clinical detail: routine laboratory measures marketed as “insulin resistance tests” do not have enough accuracy or clinical usefulness to be routinely relied upon for diagnosis of insulin resistance. The international guideline instead emphasizes broader assessment of metabolic health and risk.
In practical terms, that means we should move away from the idea that one number can explain everything.
Blood glucose.
Lipids.
Blood pressure.
Body composition.
Lifestyle.
Family history.
And the broader clinical picture may all matter.
WHO also links the condition with increased risks of insulin resistance, type 2 diabetes, obesity, hypertension, abnormal cholesterol and cardiovascular disease.
So when someone says:
“My periods are irregular, but my real problem is weight gain.”
those two things may not be unrelated.
But what about women who are not overweight?
This is another misconception worth challenging.
PMOS is not synonymous with obesity.
A woman does not need to have a particular body size to develop the syndrome. Current guidance specifically recommends focusing on healthy lifestyle and prevention of excess weight gain even in women who are not overweight.
That distinction matters because otherwise women who do not “look like they have PCOS” may have their symptoms dismissed.
The body does not read stereotypes.
Hormonal disorders do not always come with the appearance people expect.
PMOS does not stop at the reproductive system
The broader picture becomes even clearer when mental health enters the conversation.
The international guideline highlights a significantly increased prevalence of depressive symptoms and depression among adults and adolescents with PCOS, and recommends screening for depression in both groups. Anxiety screening is also recommended for adults. Body image, eating disorders, self-esteem and psychosexual concerns can also become part of the clinical picture.
That means a woman struggling with PMOS may not simply be dealing with an “irregular period problem.”
She may be dealing with a combination of:
Hormonal symptoms
Skin and hair changes
Metabolic concerns
Fertility worries
Body-image distress
Anxiety or depression
And these issues can interact with each other.
That is why treating one visible symptom while ignoring everything else may not address the full burden of the condition.
Clinical snapshot: the symptom that gets blamed on lifestyle
Illustrative case
A university-going woman notices that her periods have become increasingly unpredictable. She also develops facial acne and unwanted hair.
Her first explanation is simple:
“Maybe it is stress.”
Then:
“Maybe I am eating badly.”
Then:
“Maybe I just need to lose weight.”
Sometimes lifestyle absolutely matters. But lifestyle should not become a reason to stop asking clinical questions.
Persistent menstrual irregularity, hyperandrogenic symptoms and other features deserve proper assessment rather than being automatically attributed to a busy routine or poor lifestyle.
The 2023 international guideline emphasizes that menstrual irregularity should prompt appropriate assessment, while diagnosis requires consideration of the overall clinical picture and exclusion of alternative causes.
Teenagers are a different diagnostic story
This part is particularly important because puberty itself can produce changes that look similar to PMOS.
Irregular cycles are common in the early years after menarche, which makes diagnosis in adolescents more difficult.
Current international guidance takes a stricter approach in this age group: adolescents with suspected PMOS require both ovulatory dysfunction and hyperandrogenism, after other causes have been excluded. Ultrasound and AMH are not recommended for diagnosis in adolescents because of poor specificity during this developmental stage.
In other words:
An irregular cycle in a teenager is not automatically PMOS.
But it should not automatically be ignored either.
Sometimes the right clinical decision is not an immediate label.
It is careful observation, appropriate assessment and follow-up.
PMOS and fertility: a concern, not a sentence
Fertility is one of the reasons many women first discover they have PMOS (formerly known as PCOS).
Ovulatory dysfunction can make conception more difficult, and PCOS remains one of the major causes of anovulatory infertility. WHO describes PCOS as a leading cause of infertility and notes that management can improve fertility outcomes.
But this is another place where wording matters.
PMOS can affect fertility. It does not mean that pregnancy is impossible.
The treatment strategy depends on the individual's situation, including whether the goal is cycle control, management of androgen-related symptoms, metabolic risk reduction or pregnancy.
That is why “one treatment for PMOS” is not a very useful concept.
The better question is:
“Which part of PMOS are we trying to manage for this particular woman?”
So what does PMOS management actually look like?
There is no single universal PMOS treatment plan because there is no single universal PMOS presentation.
Management may involve several different goals:
Improving menstrual regularity
Managing acne or unwanted hair growth
Supporting metabolic health
Addressing fertility
Managing psychological symptoms
Improving sleep and overall quality of life
Lifestyle management remains a core component of care. The international guideline recommends healthy eating and physical activity for all women with PCOS, not simply as a weight-loss strategy but also for metabolic health, general health and quality of life.
Medical treatment, when required, should then be selected according to the person's symptoms, risks and reproductive goals.
In other words, PMOS care should be personalized, not copied from somebody else's treatment plan.
The biggest misconception to leave behind
Maybe the most useful way to think about PMOS is this:
The ovaries are part of the picture. They are not the entire picture.
The new name does not mean the condition suddenly became different in 2026. The international guideline update explicitly states that the existing recommendations and clinical content remain unchanged; what changed was the terminology. The next full international guideline update is planned to incorporate PMOS as standard terminology.
What has changed is the way the condition is being framed.
And sometimes changing the frame changes what we notice.
Instead of asking only:
“What do the ovaries look like?”
we can ask:
“What is happening with hormones, ovulation, metabolism, skin, mental health and long-term health?”
That is a much bigger clinical conversation.
The takeaway
PMOS is not simply a condition of ovarian cysts.
It is a complex, long-term condition involving endocrine, metabolic, ovarian and reproductive health, with possible effects on skin, weight management, mental health and quality of life.
And perhaps the most important thing for women to know is that symptoms do not always arrive as one neat package.
Sometimes the first clue is an irregular period.
Sometimes it is acne.
Sometimes unwanted facial hair.
Sometimes difficulty conceiving.
Sometimes metabolic changes.
And sometimes, it is the combination of several things that finally makes the picture clear.
PMOS is more than an ovarian problem—and understanding that may be the first step toward understanding the condition itself.
Frequently Asked Questions
What is PMOS?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome, the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS). The terminology was adopted following an international consensus process in 2026.
Is PMOS the same as PCOS?
Yes. PMOS refers to the same underlying condition previously called PCOS. The 2026 terminology update did not create a new disease or replace the established clinical recommendations.
Do you need ovarian cysts to have PMOS?
No. Ovarian cysts are not required for diagnosis. In adults with irregular cycles and hyperandrogenism, ovarian ultrasound is not required for diagnosis.
What are common PMOS symptoms?
Symptoms may include irregular or absent periods, abnormal ovulation, acne, excess facial or body hair, scalp hair thinning and difficulty conceiving. Metabolic and psychological features may also occur.
Can someone have PMOS without being overweight?
Yes. Body weight alone does not determine whether someone has PMOS, and the condition can occur across different body sizes.
Can PMOS affect fertility?
Yes. PMOS can cause ovulatory dysfunction and is a major cause of anovulatory infertility, but having PMOS does not mean pregnancy is impossible.
Is PMOS only a hormonal condition?
No. The new terminology specifically reflects the broader endocrine, metabolic and ovarian dimensions of the condition.
Should teenagers with irregular periods be diagnosed with PMOS immediately?
Not necessarily. Adolescents require age-appropriate assessment because normal puberty can overlap with PMOS features. Current guidance requires both ovulatory dysfunction and hyperandrogenism for adolescent diagnosis and does not recommend ultrasound or AMH for diagnosis in adolescents.
